A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response to Pseudoephedrine Concurrent With Placebo or TR 701 FA.
Phase of Trial: Phase I
Latest Information Update: 09 Oct 2017
At a glance
- Drugs Tedizolid (Primary) ; Pseudoephedrine
- Indications Bacteraemia; Bacterial infections; Gram-positive infections; Skin and soft tissue infections
- Focus Pharmacodynamics
- Sponsors Trius Therapeutics
- 12 Jun 2013 Results were published in Antimicrobial Agents and Chemotherapy, according to a Trius Therapeutics media release.
- 29 Apr 2013 Results presented at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) meeting, according to a Trius Therapeutics media release.
- 11 Sep 2012 Results will be presented at ICAAC-2012 according to a Trius Therapeutics media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History